info@targetmol.com    Tel: (781) 999-4286 / (857) 239-0968
Home > Immunology/Inflammation > HDAC > BML-210
BML-210  
Catalog No. T3204    CAS 537034-17-6
Pack Size
Availability
Price/USD
Quantity
5mg
In stock
68.00
10mg
In stock
102.00
25mg
In stock
224.00
50mg
In stock
425.00
1g
Get quote
0.00
5g
Get quote
0.00
10mM * 1mL (in DMSO)
In stock
75.00
Bulk Size: Please Quote for Discount
Documents and Quality Management
Purity:99.00% COA Datasheet HNMR HPLC MSDS
Biological Activity:

Product Description:

BML-210 is the novel HDAC inhibitor, and its mechanism of action has not been characterized.

Target:
HDAC;
Research Area:
Cancer
Chemical Information:
Molecular Weight 339.43
Formula C20H25N3O2
CAS Number 537034-17-6
Solubility DMSO:≥30 mg/mL
Storage 3 years -20°C powder;
2 years -80°C in solvent;
Remark For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ℃ for several month.
Technical Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store Products, and issues that need special attention for cell-based assays and animal experiments.

Related Compound Libraries
This product is contained In the following compound libraries:
Product Recommendations
  • GSK-J4 Hydrochloride, GSK J4 HCl is a cell permeable prodrug of GSK J1, which is the first selective inhibitor of the H3K2...
  • GSK2879552 2HCl, GSK2879552 is an orally available, irreversible inhibitor of lysine specific demethylase 1 (LSD1), w...
  • PRIMA-1Met, PRIMA-1MET restores wild-type conformation and function to mutant p53, and triggers apoptosis in tum...
  • Roquinimex, Roquinimex (Linomide) is a quinoline derivative immunostimulant which increases NK cell activity and...
  • Gilteritinib, Gilteritinib is a potent inhibitor at the FMS-related tyrosine kinase 3 (FLT3) and AXL tyrosine kina...

 

Reference

If you have additional questions, Please send us a message. * Required